Table: Cytori Cell Research Institute -2024/25 group results

ADR Biomedical Holdings

15/05/2025 10:00

May 15 (Reuters)- 
          Cytori Cell Research Institute, Inc. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                    Year ended      Year ended       Year to       NEXT   
                 Mar 31, 2025    Mar 31, 2024   Mar 31, 2026     YEAR     
                    LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS          RESULTS       FORECAST    H1 FORECAST 
  Sales            122 mln           1.56           1.06                  
                 (-92.2 pct)      (-27.2 pct)   (+767.5 pct)              
  Operating      loss 806 mln    loss 772 mln   loss 123 mln              
  Recurring      loss 864 mln    loss 906 mln   loss 138 mln              
  Net
  Net             loss 2.14         138 mln        71 mln                 
  EPS          loss 239.70 yen     15.47 yen      8.04 yen                
  EPS Diluted                      15.42 yen                              
  Ann Div            NIL              NIL                                 
  -Q2 Div            NIL              NIL                                 
  -Q4 Div            NIL              NIL                                 
  
  NOTE - Cytori Cell Research Institute, Inc..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3750.T